Discover Université Paris-Saclay’s most Highly Cited Researchers in 2024
Since 2014, Clarivate Analytics has published an annual list of researchers who have demonstrated significant and broad influence in their field(s) of research over the past decade. These Highly Cited Researchers have published scientific publications which rank in the top 1% by citations for their field(s) and publication year in the Web of Science™ index. In 2024, the following 24 researchers from Université Paris-Saclay were named on the list:
Laurence Albiges is a medical oncologist and head of the Medical Oncology Department at Gustave Roussy. She is a member of the team specialised in the impact of tumour microenvironment on tumour resistance within the unit for Integrative Tumour Immunology and Immunotherapy (INTIM – Univ. Paris-Saclay, Institut Gustave-Roussy, Inserm, EPHE). Also a professor at Université Paris-Saclay, Laurence Albiges is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Fabrice André is an oncologist within the Breast Pathology Committee at Gustave Roussy, and head of the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). Also head of the team specialised in the molecular characterisation of breast and gynaecological cancers, he is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Fabrice Barlesi specialises in lung cancer, precision medicine and cancer immunology. Director General of Gustave Roussy and professor of medicine at Université Paris-Saclay, he is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Benjamin Besse specialises in thoracic cancers and is a clinical research director at Gustave Roussy. He is also a professor at Université Paris-Saclay, and a member of the team specialised in genetic tumour adaptation to kinase inhibitors within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). He is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Claire Chenu is a professor in soil science at AgroParisTech, and a research director at the Functional Ecology and Ecotoxicology of Agroecosystems Laboratory (Ecosys – Univ. Paris-Saclay, AgroParisTech, INRAE). Claire Chenu is one of the world’s most highly cited researchers in the category for “Agricultural Sciences”.
Philippe Ciais is a research director at the Laboratory for Sciences of Climate and Environment (LSCE – Univ. Paris-Saclay, UVSQ, CEA, CNRS). He is one of the world’s most highly cited researchers in the categories “Environment & Ecology” and “Geosciences”.
Frédéric Chevallier is a research scientist at the Laboratory for Climate and Environmental Sciences (LSCE-IPSL – Univ. Paris-Saclay, UVSQ, CEA, CNRS) and head of the Inverse modelling for atmospheric and satellite measurements team. He is one of the world’s most highly cited researchers in the “Cross-Field” category.
Franck Courchamp is an ecologist and CNRS research director at the Ecology, Systematics and Evolution Laboratory (ESE – Univ. Paris-Saclay, CNRS, AgroParisTech). Franck Courchamp is one of the world’s most highly cited researchers in the category for “Environment & Ecology”.
Stanislas Dehaene is a neuroscientist specialised in cognitive psychology and professor at Collège de France. He is also a research director at and head of the Cognitive Neuroimaging Unit (Unicog – Univ. Paris-Saclay, CEA). Stanislas Dehaene is one of the world’s most highly cited researchers in the “Cross-Field” category
Charles-Antoine Dutertre is a researcher at the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy). He is one of the world’s most highly cited researchers in the “Cross-Field” category.
Stanislav Dusko Ehrlich was the former scientific and technical head of the preindustrial demonstrator project MetaGenoPolis (MGP – Univ. Paris-Saclay/INRAE) and the former scientific director of the INRAE unit. He is one of the world’s most highly cited researchers in the “Cross-Field” category.
Albert Fert was awarded the Nobel Prize for Physics in 2007 for the discovery of giant magnetoresistance (GMR). He is an Emeritus Professor at Université Paris-Saclay and a former researcher at the Albert Fert Laboratory (Univ. Paris-Saclay, CNRS, Thales), which he co-founded. He is one of the world’s most highly cited researchers in the “Cross-Field” category.
Karim Fizazi is a medical oncologist specialised in prostate cancer and head of the Genitourinary Committee at Gustave Roussy. He is also a professor of oncology at Université Paris-Saclay and a member of the team specialised in adaptative resistance to anticancer-therapies within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). Karim Fizazi is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Florent Ginhoux is a laboratory director at Gustave Roussy and a visiting associate professor at several prestigious universities: Mount Sinai School of Medicine (MSSM) in New York, the Shanghai Institute of Immunology, the Institute for Translational Immunology and Duke NUS Medical School in Singapore. He is also an associate professor at Gustave Roussy within the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy). He is one of the world’s most highly cited researchers in the category for “Immunology”.
Marc Humbert is a professor of pneumology at Université Paris-Saclay and head of the Pulmonology and Respiratory Intensive Care Department at Bicêtre Hospital, where he is also head of the Reference Centre for Pulmonary Hypertension. He manages the Pulmonary Hypertension: Physiopathology and Therapeutic Innovation Laboratory (HPPIT – Univ. Paris-Saclay, Inserm). Since 2023, he has been dean of the Faculty of Medicine at Université Paris-Saclay. Marc Humbert is one of the world’s most highly researchers in the category for “Clinical Medicine”.
Aurélien Marabelle is a medical oncologist and professor at Université Paris-Saclay. He is head of the Translational Research in Immunotherapy Laboratory (LRTI), linked to the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy). He is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Xavier Mariette is head of the immunology and rheumatology service at Bicêtre hospital and professor of rheumatology at Université Paris-Saclay. He leads the team specialised in autoimmunity at the Infectious Disease Models and Innovative Therapies Laboratory (IMVA-HB – Univ. Paris-Saclay, Inserm, CEA). Xavier Mariette is one the world’s most highly cited researchers in the category for “Clinical Medicine”.
David Planchard is a thoracic oncologist and professor at Université Paris-Saclay. He is head of the thoracic pathology committee at Gustave Roussy, where he coordinates the treatment of patients with lung cancer, pleural mesothelioma or thymic tumours. He is a member of the team specialised in genetic tumour adaptation to kinase inhibitors within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm) and is also chair of the International Thoracic Cancer Centre. David Planchard is the one the world’s most highly cited researchers in the category for “Clinical Medicine”.
Marco Di Renzo is a research director at the Laboratory of Signals and Systems (L2S – Univ. Paris-Saclay, CentraleSupélec, CNRS) where he is head of the team specialised in intelligent physical communications. He is a pioneer in metamaterials and wireless networks, for which he has created numerous models and algorithms. Marco Di Renzo is one of the world’s most highly cited researchers in the category for “Computer Science”.
Caroline Robert is head of dermatology at Gustave Roussy and professor at Université Paris-Saclay. She also oversees teaching in dermatology at the university’s Faculty of Medicine. She is also head of the team specialised in adaptative resistance to anticancer-therapies within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). Caroline Robert is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Gérald Simonneau is an Emeritus Professor at Université Paris-Saclay and pulmonologist at the Pulmonary Hypertension: Physiopathology and Therapeutic Innovation Laboratory (HPPIT – Univ. Paris-Saclay, Inserm). He is a specialist in Pulmonary Arterial Hypertension, and has contributed to the discovery of key medicine which has transformed the prognosis of the rare disease. Gérald Simonneau is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Jean-Charles Soria is a world-renowned medical oncologist, specialised in precision medicine, immunotherapy and lung cancer. He is professor of medicine and medical oncology at Université Paris-Saclay. Jean-Charles Soria was Director General of Gustave Roussy, Europe’s leading cancer centre, from January 2020 to July 2021. He is one of the world’s most highly cited researchers in the category for “Clinical Medicine”.
Laurence Zitvogel is a medical oncologist at Gustave Roussy and a professor of immunology at Université Paris-Saclay. She is head of the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy). Laurence Zitvogel is one of the world’s most highly cited researchers in the category for “Immunology”.